katie sturino glp 1 Body acceptance advocate discusses her decision to take GLP-1 weight loss drugs How I got on a
Description
Diabetes Care, 43(10), 25092518
Despite the valuable insights gained from this scoping review, several limitations should be acknowledged
Alongside these incretin receptor agonists, GIP receptor antagonists have garnered significant interest, driven by evidence suggesting that endogenous GIP exacerbates obesity and insulin resistance in high-fat dietary conditions [19]
Depending on patient-specific factors and associated risks, anesthesia providers could consider treating these patients as if they have a full stomach
13 September 2024
The widespread use of weekly injectable GLP-1RA has improved acceptability of this therapy
